New Enterprise Associates

New Enterprise Associates, Inc. is a private equity and venture capital firm founded in 1977 and headquartered in Menlo Park, California, with additional offices in India and China. The firm specializes in investing across various stages of business development, from seed funding to public offerings, with a strong emphasis on the technology and healthcare sectors. Its investment strategy encompasses a wide range of industries, including information technology, consumer internet, financial technology, software, healthcare services, life sciences, biopharmaceuticals, and energy technology. New Enterprise Associates actively engages with entrepreneurs to support the growth of their companies, making investments between $0.05 million and $20 million. The firm has a global investment focus, particularly in regions such as Asia, Brazil, and the United States.

Michael Albert

Associate

Kate Barrett

Partner, Communications

Barris, Peter J.

Chairman

Forest Baskett

General Partner

Ali Behbahani

General Partner

Ron Bernal

Venture Partner

Burns, Zak

Associate

James Buxton MD

Principal

Carmen Chang

Partner, Chair and Head of Asia

Philip Chopin

Managing Director, NEA UK

Pamela Clark

General Partner

Vanessa Deng

Associate

Chris Doppman

Principal, LP Relations

Tony Florence

General Partner

Graf, Albert Jay

Venture Partner

Arjun Jain

Senior Associate

James Kaplan

Associate

Kerins, Patrick J.

General Partner

Nick Kline

Principal, LP Relations

Danielle Lay

Principal

Le, Tiffany

Senior Associate

Michael Li

Principal

Luck, Tiffany

Partner

Makhzoumi, Mohamad H.

General Partner

Matthew McAviney

Partner

Mukherjee, Amit

Partner

Bibhash Mukhopadhyay

Principal

Kemi Odusan

Senior Associate

Greg Papadopoulos

Venture Partner

Pappas, Luke

Principal

Park Ph.D., Michele S.

Partner

Eileen Qian

Associate

Sandell, Scott D.

Managing General Partner

Tim Schaller

CFO

Schoen, Andrew Adams

Partner

Alex Sharata

Associate

Peter Sonsini

General Partner

Brad Thawley

Partner, Limited Partner Relations

Blake Wu

Partner

Lulu Xu

Principal

Emily Zhen

Associate

J.C. Lopez MD

Principal

Past deals in Series A

Union.ai

Series A in 2023
Union.ai is a Kubernetes-native workflow orchestration platform for data and machine learning at scale. Union.ai provides software users with the tools they need to move their ideas from concept to high-quality production. Union's aim is to organize the numerous processes required to train and grow the most sophisticated and dynamic machine learning and data products.

Kira

Venture Round in 2023
Kira Learning is an AI-driven education technology company that creates innovative tools and solutions to support educators and students. Its primary mission is to empower schools, districts, and teachers by integrating cutting-edge artificial intelligence into educational practices, making teaching more effective and learning more engaging.

SimpleRose

Venture Round in 2023
SimpleRose is a technology company that allows customers to optimize and accelerate decision-making. The company's applications include scheduling, production planning, and portfolio optimization.

Flox

Series A in 2023
Flox develops a web application that enhances developer productivity throughout the software development lifecycle. The company offers SaaS products that leverage Nix, allowing enterprises to install packages, manage development and production environments, and ensure consistent software deployment across embedded devices. By enabling developers to treat environments and packages as code, Flox streamlines the process of building and managing software, promoting efficiency and reliability in development practices.

Bliq

Series A in 2022
Bliq helps gig workers in the transport industry to automate the organization of their daily work. The “Bliq Ride” app allows registered drivers to accept or reject orders from multiple platforms. Bliq was founded in 2019 by Julian Glaab (CEO), Johannes Riedel (COO), and Torgen Hauschild (CTO). The company is based in Berlin and currently employs 25 people.

Arkestro

Series A in 2022
Arkestro is a predictive procurement software for businesses to boost savings and supply chain performance by pre-embedding preferred outcomes in any system or process. With Arkestro, businesses can orchestrate their activities across systems using instant forecasts and real-time collaboration. Predict and win 2–5x faster savings and never get stuck waiting for a KPI report again.

Bliq

Series A in 2022
Bliq helps gig workers in the transport industry to automate the organization of their daily work. The “Bliq Ride” app allows registered drivers to accept or reject orders from multiple platforms. Bliq was founded in 2019 by Julian Glaab (CEO), Johannes Riedel (COO), and Torgen Hauschild (CTO). The company is based in Berlin and currently employs 25 people.

Jomboy Media

Series A in 2022
We cover the topics we love, including sports, movies, songs, and history. If we can talk about it with enthusiasm, we've got a show for it.

Wheelhouse

Series A in 2022
Wheelhouse is a business intelligence platform that helps turn the hosts & owners into superheroes. We're proud that thousands of hosts & owners have used our flagship product, data-driven pricing, to earn significantly more revenue from their business. We're a team of YC alums, data science PhD's, hedge fund engineers, product evangelists, and hustlers. Our teams core values are "empowered together" and "seriously fun". We think that captures the mood & values of a team that works exceptionally well together, pushes the envelope, and is not against cracking a beer together around 5pm on Friday. See more team members here: - https://angel.co/usewheelhouse - https://www.usewheelhouse.com/about-us

NODAR

Series A in 2022
NODAR develops a camera-based 3D vision system for autonomous vehicles that provides unprecedented accuracy. The safety of these vehicles depends on the reliability and performance of their 3D sensors. NODAR is building the next generation of camera-based 3D vision technology that delivers the performance, reliability, and price required by mainstream automotive.

Evernow

Series A in 2022
Evernow is a provider of women's health care services before, during, and after menopause. Their platform has online access to specialized doctors, science-backed information, and treatments, along with conversations and information about effective care for changing hormones, enabling women to live longer and healthier lives.

Antimatter

Series A in 2022
Antimatter is a cryptographic infrastructure service enabling B2B SaaS companies to provably guarantee the security of their customers' data, fundamentally solving the challenges of data security and privacy requirements without requiring any changes to code. Antimatter was founded in 2021 and is based in Oakland, California.

Clockwork Systems

Series A in 2022
Clockwork Systems is a technology enables next generation time-sensitive applications in on-prem data centers, public clouds, and hybrid environments.

SafeBase

Series A in 2022
SafeBase develops a smart trust center platform for sharing security posture and automating access to sensitive documents for enterprise programs. Its software offers custom security checklists, and continuous monitoring of security systems, and configures security policies to allow companies to implement security practices.

Alfred

Venture Round in 2022
Founded in 2014 by Marcela Sapone and Jessica Beck, Alfred is the largest and most advanced residential management platform. Since its inception, Alfred has focused on providing a resident-first experience. With an unparalleled knowledge of what residents want and technology that boosts income and efficiency for owners and operators, Alfred provides a single stop that elevates the rental ecosystem for all involved. Named by Fast Company as one of the Top 50 Most Innovative Companies, Alfred’s AOS technology drives lower operating costs and higher returns for property owners and operators. Through strategic partnerships with international real-estate owners and operators such as Hines, Related, RXR, Greystar, Invesco, Brookfield and J.P. Morgan, With RKW, Alfred’s portfolio now extends to more than 300,000 residents in 44 cities across the U.S. and Canada and has planned expansions in Europe, Israel and Asia.

Weaviate

Series A in 2022
Weaviate develops a hybrid SaaS platform to build search and recommendation systems. Its open-source AI vector search engine has extensions in the platform for specific use cases such as semantic search, plugins to integrate into any application, and a console to understand their data.

Splice Bio

Series A in 2022
Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations of adeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.

FTX US

Series A in 2022
Operator of a bitcoin options exchange intended to help individual traders and institutions trade more bitcoin. The company's platform allows users to trade in bitcoin, derivatives, clearing, options, and digital currency, enabling international traders to trade in cryptocurrencies.

Waymark

Series A in 2022
Waymark is a company dedicated to improving access and quality of care for people receiving Medicaid.

Sorriso Pharmaceuticals

Series A in 2021
Sorriso Pharmaceuticals is a biotechnology company advancing a pipeline of disease-modifying antibodies for the treatment of inflammatory disease, including Crohn’s disease and ulcerative colitis. The Sorriso platform generates potent antibodies that can be delivered orally and are designed to maintain activity throughout the intestinal system. The company was founded in 2020 and is based in San Diego, California.

Belong Health

Series A in 2021
Belong Health works with local health plans to provide regionally informed, humanistic care to a rapidly expanding community of need.

Wonder

Series A in 2021
Wonder is a gaming company focused on creating an all-in-one gaming platform for Android mobile devices. The platform enables users to play, stream, and share games seamlessly across various devices, thereby enhancing the overall gaming experience. In addition to its software solutions, Wonder is also involved in developing VR-ready gaming hardware. Currently, the company operates in stealth mode, suggesting that it is in the early stages of development and may be working on innovative features or products.

AviadoBio

Series A in 2021
AviadoBio is focused on developing innovative gene therapies aimed at transforming the lives of individuals affected by neurodegenerative disorders, specifically frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The company leverages advanced research from King's College London and the UK Dementia Research Institute to create its therapeutic platform. By integrating a comprehensive understanding of brain biology with proprietary gene therapy techniques, AviadoBio seeks to address the challenges of effectively delivering treatments to targeted areas in the brain. This approach aims to enhance the therapeutic potential of gene therapies, offering hope for halting or potentially reversing the progression of these debilitating diseases.

Tune Therapeutics

Series A in 2021
Tune Therapeutics strives to develop paradigm-changing cell and gene therapies that leverage epigenetic programming for the treatment of devastating diseases.

Recludix Pharma

Series A in 2021
Recludix Pharma is a biotechnology company focused on drug discovery, specifically targeting the development of potent and selective inhibitors for challenging protein targets associated with cancer and autoimmune diseases. The company utilizes a unique platform that combines custom-generated DNA-encoded libraries with massively parallel structure-activity relationship determination and proprietary screening tools. This integrated approach aims to enhance the identification and development of novel small molecule medicines, enabling healthcare professionals to create precision therapies that effectively address specific protein targets in these complex diseases.

Datafold

Series A in 2021
Datafold builds tools for automating analytical data quality management. It helps companies extract more value from their analytical data by automating Data Engineering workflows like data quality monitoring. It also simplifies data QA by enabling instant table comparison and profiling.

Merge

Series A in 2021
Merge is one API to add hundreds of integrations to your product. Merge’s platform makes secure data access easy by offering Unified APIs across key software categories, including HRIS, accounting, CRM, file storage, and more. Merge handles the full integrations lifecycle — from an easy initial build taking just weeks, to providing integration observability tools ensuring customer delight, and fully owning the maintenance of integrations. Thousands of companies use Merge to power their integrations, enabling them to unblock sales, reduce customer churn, accelerate time to market for new products, and save engineering costs and resources. Merge is backed by $75 million in funding from Accel, NEA, and Addition. Merge was founded in 2020 by Shensi Ding and Gil Feig and is proudly built in San Francisco, New York City, and Berlin.

Candy

Series A in 2021
Candy is a multifaceted company that operates in the digital collectible and confectionery sectors. It develops sports and culture digital assets, providing authentic digital experiences that engage fans and connect them with their interests. Additionally, Candy.com serves as an online retailer catering to the growing demand for bulk, gourmet, and gift confectionery products, offering competitive pricing, expedited shipping, and a unique shopping experience. Furthermore, Candy Digital specializes in non-fungible tokens (NFTs), enabling fans to buy and trade officially licensed tokens related to Major League Baseball. Launched in 2021, this segment of the business was established by notable figures in the industry and reflects Candy's commitment to integrating technology with fan engagement.

Wizard

Series A in 2021
Wizard is a software development company that offers B2B solutions for brands to sell and market products directly through text.

Slope.io

Series A in 2021
Slope connects a clinical trial to its supply chain, coordinating the operational complexity of getting devices, drugs, & kits from suppliers to sites to patients in real-time with complete traceability.

Neural Magic

Series A in 2021
Neural Magic specializes in enterprise inference solutions that optimize the performance of open-source large language models (LLMs) across various infrastructures. The company focuses on maximizing computational efficiency and hardware utilization, enabling organizations to deploy AI models securely and cost-effectively.

858 Therapeutics

Series A in 2021
858 Therapeutics is a biotechnology company focused on discovering small molecule therapeutics for novel targets in oncology and immunology. The company emphasizes innovative approaches in synthetic lethality, innate immunity, and RNA modulation. Its lead program is a PARG inhibitor currently in early clinical development.

Workera

Series A in 2021
Workera is a precision upskilling platform that helps enterprises, governments, and individuals upskill and reskill to meet the critical demand for key technological capabilities, including data science, machine learning, and artificial intelligence. The Workera platform provides AI-driven mentorship at scale with its adaptive assessments and personalized learning plans that drive measurable results to close the skills gap.

Vori Health

Series A in 2021
Vori Health offers a new care delivery model for treating musculoskeletal conditions. Its nationwide, all-inclusive medical practice is evidence-based and uniquely positioned to address a multitude of back, neck, and other joint issues. The organization offers integrated medical and rehabilitation care, physical therapy, prescriptions, imaging and lab ordering, health coaching, nutritional guidance, community support and premium instructional content. Using a unique, virtual-first care model to help patients find the best path forward, Vori Health connects patients to a trained care team that includes a board-certified, non-operative physical medicine physician, a health coach navigator, and a physical therapist who collaboratively manage the initial patient assessment and coordinate all aspects of care. Learn more at www.vorihealth.com. The company was founded in 2020 and is headquartered in New York, NY.

Stablix

Series A in 2021
Stablix Therapeutics is a biotechnology company specializing in Targeted Protein Stabilization (TPS). The company has developed a platform that produces heterobifunctional small molecules, known as RESTORACS, which selectively recruit deubiquitinase enzymes to remove ubiquitin from targeted proteins. This process enhances the stability and activity of these proteins. Stablix focuses on utilizing its innovative technology to create therapeutic programs aimed at treating rare diseases, cancer, and immunological disorders. By restoring protein function, Stablix aims to provide more effective treatment options for complex medical conditions.

Vori Health

Series A in 2021
Vori Health offers a new care delivery model for treating musculoskeletal conditions. Its nationwide, all-inclusive medical practice is evidence-based and uniquely positioned to address a multitude of back, neck, and other joint issues. The organization offers integrated medical and rehabilitation care, physical therapy, prescriptions, imaging and lab ordering, health coaching, nutritional guidance, community support and premium instructional content. Using a unique, virtual-first care model to help patients find the best path forward, Vori Health connects patients to a trained care team that includes a board-certified, non-operative physical medicine physician, a health coach navigator, and a physical therapist who collaboratively manage the initial patient assessment and coordinate all aspects of care. Learn more at www.vorihealth.com. The company was founded in 2020 and is headquartered in New York, NY.

Rapid Robotics

Series A in 2021
Growing labor shortages combined with the rising complexity of material handling and fulfillment mean that manufacturing and logistics businesses need a palletizing solution that can adapt to their evolving needs. Rapid Robotics is a full-service robotic palletizing company deploying fleets of affordable robotic workcells designed to respond to the dynamic conditions of today's business. Rapid’s AI, vision-based platform was created to handle a wide range of palletizing use cases. With the option of a RaaS business model combined with pioneering speed, service, and support it becomes possible to increase capacity and predictability at the end of the line without the risk and complexity of owning and maintaining robots.

Goody

Series A in 2021
Goody makes sending gifts as easy as sending a text. No address needed. It accepts payments only when the gift is received.

Theorycraft Games

Series A in 2021
Theorycraft Games operates as an independent game development studio that operates remotely. The company is in process of developing its first game codenamed Loki. Theorycraft was founded in 2020 and is headquartered in Los Angeles, California, United States.

Sagimet Biosciences

Venture Round in 2021
Sagimet Biosciences is a clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat important diseases such as the liver disease NASH and specific cancers, with focus on targeting dysfunctional metabolic pathways. The company has unique expertise in FASN biology and has created a pipeline of proprietary FASN inhibitors.

Rocket.Chat

Series A in 2021
Rocket.Chat is a fast-growing enterprise communication and collaboration platform that is now installed on over 500k servers and counts over 12m users worldwide as well as having an active, passionate community of over 1k developer-contributors who help Rocket.Chat’s core team of developers to constantly improve the product. Rocket.Chat’s long-term vision is to replace email with a real-time federated communications platform and to establish a marketplace that will nurture app-building and offer services to enable businesses to be built using Rocket.Chat. The platform improves internal and external communication within a controlled and secure environment. Users can run Rocket.Chat on-premises or on cloud and a range of features are at their disposal to tailor their platform: individual and group communication, video conferencing, file uploading, screen sharing, LiveChat, and integration with a variety of different communications platforms.

Narmi

Series A in 2021
Narmi is a provider of mobile, online, and digital account banking to regional and community financial institutions. Its platform enables financial institutions to open accounts in less than 2.5 minutes, and then grow that relationship over a lifetime through intuitive mobile and online channels.

New Wave Foods

Series A in 2021
New Wave Foods is a provider of algae and plant-based food used to preserve and enrich seafood traditions. Its foods are sustainable, plant-based shrimp alternatives made from sustainably sourced seaweed, soy protein, and natural flavors which contain the eight amino acids that are found in meats that enable consumers to enjoy low calories and zero cholesterol healthy products.

POLYNEURON

Series A in 2020
Polyneuron is a developer of novel therapeutics intended to facilitate the treatment of antibody-mediated autoimmune diseases. The company's biodegradable glycopolymers-based therapeutics selectively eliminate the pathological autoantibodies, while leaving the rest of the immune system intact, enabling medical practitioners to treat patients with immune disorders in a safe and effective manner.

Korro Bio

Series A in 2020
Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms. Korro Bio was created to lead the field of RNA editing. The company is advancing a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues. In 2018,

GRID

Series A in 2020
GRID is a productivity tool that transforms everyday Excel spreadsheets into modern web applications, allowing users to create interactive web documents without requiring new skills. This platform offers an editor that automates the conversion process, enabling users to generate visually appealing and interactive web reports from their spreadsheets. Additionally, GRID facilitates secure sharing and analysis of these documents, empowering clients to turn traditional spreadsheets into dynamic dashboards or applications that enhance collaboration and usability.

MBX Biosciences

Series A in 2020
MBX Biosciences is a biotechnology company that develops therapies to treat rare endocrine diseases where there is inadequate treatment available. It focuses on the discovery, development, and commercialization of first-in-class endocrine therapeutics.

Monte Rosa Therapeutics

Series A in 2020
Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways. Its rational approach in targeting disease-causing proteins for degradation will deliver pioneering therapies for cancer and beyond.

Beyond Identity

Series A in 2020
Beyond Identity's mission is to empower the next generation of secure digital business by replacing passwords with fundamentally secure X.509-based certificates. This patent-pending approach creates an extended Chain of Trust that includes user and device identity and a real-time snapshot of the device’s security posture for adaptive risk-based authentication and authorization. Beyond Identity’s cloud-native solution enables customers to increase business velocity, implement new business models, reduce operating costs, and achieve complete passwordless identity management.

Vimaan

Series A in 2020
VIMAAN is a computer vision and AI solution company that helps warehouses keep track of their inventory. Their solution automates and digitizes all inventory tasks, from receiving and putting things away to picking them up for orders, counting stock, checking orders, and shipping them out. Vimaan was founded to address the longstanding challenge of keeping accurate track of inventory in warehouses.

Affinia Therapeutics

Series A in 2020
Affinia Therapeutics is a developer of a platform for rationally designed adeno-associated virus (AAV) vectors and gene therapies intended to develop medicines for devastating diseases. The company leverages synthetic and systems biology combined with high-throughput screening and tissue and single-cell resolution for people affected by muscle and central nervous system (CNS) diseases with significant unmet needs, thereby providing medical professionals with the rational design of novel vectors and gene therapies with remarkably improved properties.

ClearMetal

Series A in 2020
ClearMetal, Inc., based in San Francisco, California, specializes in artificial intelligence software for supply chain operations, focusing on transport and supply chain visibility solutions. Founded in 2014 by experts from Stanford University and leading technology companies, ClearMetal's platform leverages machine learning algorithms to enhance the accuracy and quality of ocean freight data. This cloud-based application consolidates and processes information from multiple sources, providing real-time insights into shipment status and enabling organizations to predict arrival times and manage exceptions effectively. By facilitating access to reliable data, ClearMetal aims to improve logistics efficiency and enhance customer experiences in supply chain management.

Dandelion Energy

Series A in 2020
Dandelion Energy, Inc., founded in 2017 and headquartered in Palo Alto, California, specializes in affordable geothermal heating and cooling solutions for residential properties. The company's innovative home geothermal system replaces traditional air conditioning and heating equipment with a heat pump and underground pipes that efficiently transfer thermal energy between the earth and the home. This proprietary installation process allows homeowners to transition from conventional heating fuels to renewable geothermal energy, providing an environmentally friendly and cost-effective alternative for temperature regulation and hot water production.

Lily AI

Series A in 2020
Lily AI is the first platform that bridges the gap between brand-speak and customer-speak to drive exponential growth for commerce companies large and small. Lily AI seamlessly injects customer-centric product attributes into site search engines, recommendation systems, SEO/SEM capabilities and item setup processes to drive exponential lifts in traffic, conversion, revenue and brand loyalty. The company is venture-backed and headquartered in Mountain View, CA.

Anyscale

Series A in 2019
Anyscale, the company founded by the creators of Ray, is accelerating the development and productionization of AI applications, at any scale. Ray, the fastest growing open source project in distributed AI, lets developers instantly scale applications from a laptop to the cloud, without the cost or expertise of building complex infrastructure. By empowering developers of all skill levels to effortlessly develop and scale the end-to-end AI lifecycle on a single compute substrate and deploy the app into production, Anyscale is enabling organizations to bring AI products to market faster and at lower costs. Backed by Andreessen Horowitz, NEA, and Addition, Anyscale is based in San Francisco, CA. www.anyscale.com

Shape Therapeutics

Series A in 2019
Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA Gene Therapy, potentially enabling the development of cures in neurodegenerative, metabolic and rare genetic diseases through our breakthrough payload, delivery, and manufacturing platform technologies. Our vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many patients as possible.

The Yes

Series A in 2019
They are co-located in Silicon Valley and New York City, but are open to great talent anywhere. They welcome critical thinkers who are excited to re-write the rules of e-commerce. They promise it will be fun.

Aquabyte

Series A in 2019
Aquabyte builds machine-learning products for aquaculture (fish) farms. Aquabyte was founded in 2017 to bring machine learning and computer vision technologies to the aquaculture industry. The company's diverse team of machine learning experts, entrepreneurs, and aquaculture biologists are hyperfocused on delivering solutions with a real-world impact. Real-time sea lice counting, biomass monitoring, and appetite detection are just a few of the many applications that will eventually be possible with the Aquabyte system. Aquabyte surpasses modern farm monitoring products with our machine-learning platform and smart camera system. The company's solution offers easy installation, continuous monitoring, and multiple applications. Aquabyte’s mission is to use machine learning to make fish farms more efficient, sustainable, and profitable.

Genies

Venture Round in 2019
Genies is culture’s leading avatar technology company empowering humans to create their own avatar experiences. To-date, Genies has been widely adopted by cultural tastemakers and has partnerships with Universal Music Group and Warner Music Group as their rosters’ “official avatar.” Genies has recently launched its consumer arm via its AR Developer Kit which allows developers to create interoperable avatar experiences for mobile and hardware AR. Their first avatar experience, Silver Studio, allows users to design and exchange digital fashion. Genies has raised $250M from investors such as Silver Lake, BOND, NEA, and Bob Iger valuing the company at $1 billion.

Block Renovation

Series A in 2019
Block Renovation is a renovation platform that combines architect-grade design, construction labor, and materials into a streamlined renovation experience. Block’s mission is to give homeowners a better way to improve the spaces they live in, and to give contractors a better way to work. Founded by Koda Wang and Luke Sherwin, Block simplifies a complex and convoluted process and delivers an intuitive experience for completing a beautiful home renovation.

Vesper Medical

Venture Round in 2019
Vesper Medical is committed to developing safe, efficacious and easy-to-use products for patients with deep venous disease and the physicians who treat them. The company's core technology, the Vesper DUO Venous Stent System, is purpose-built for venous stenting, with an unmatched combination of strength and flexibility designed to meet the multiple anatomical challenges presented by vein mechanics. Vesper Medical is advancing the treatment of deep venous disease by creating a highly differentiated, purpose-built venous stent portfolio that addresses the multiple anatomical challenges presented by the iliac and femoral veins. It also develops minimally- invasive peripheral vascular products. Vesper Medical was founded in 2016 and is headquartered in Wayne, PA, USA.

Level

Series A in 2019
Level is a neobank and mobile banking app that provides next-level banking for modern consumers consisting of an app, a cashback debit card called Level Debit Card, and an interest-bearing deposit account called Level Bank Account, offered through Evolve Bank & Trust, Member FDIC. The level is a product of Zero Financial.

ARRIS

Series A in 2019
ARRIS develops an additive molding technology for manufacturing 3D-aligned continuous fiber thermoplastic composite parts at scale. Its composites manufacturing technology combines continuously aligned fibers, electronics, and metallic components within topology-optimized structures.

Reneo Pharmaceuticals

Series A in 2019
Reneo Pharmaceuticals is an operator of a pharmaceutical company used to develop therapies for patients with orphan metabolic diseases. It focuses on the development of treatments for genetic disorders associated with defects in energy metabolism resulting in myopathy that enable caregivers to improve the daily function and quality of life of patients suffering from these diseases by improving how their mitochondria work, preserving muscle function and preventing muscle injury, weakness, and wasting. The company was founded in 2014 and is headquartered in San Diego, California.

Spyglass Ophthalmics

Series A in 2019
Spyglass Ophthalmics develops ophthalmic devices intended to improve vision and eye care of patients. Spyglass' devices address unmet needs in cataract, lens replacement, surgery, and other chronic ophthalmic diseases, enabling patients to get quality eye treatment at an affordable cost.

AppSheet

Series A in 2019
AppSheet is the intelligent no-code platform for business apps. It also enables business users to leverage their business data and build powerful, code-free apps. The company connects with a range of data sources including spreadsheets on Google Drive, Office 365, Dropbox, and Box, relational databases like SQLServer, MySQL, Postgres, AWS Aurora, and Oracle, cloud SaaS services like Salesforce, Smartsheet, AirTable, and many more. AppSheet quickly generates a working application that can be customized, enhanced, branded and deployed. The apps can be rich in function (offline access, workflow rules, machine learning, etc) and run on the web, iOS, Android, and messaging platforms. AppSheet was founded in 2014 and is headquartered in Seattle, WA, USA.

Metabase

Series A in 2019
Metabase is an open-source analytics and business intelligence application that allows users to create dashboards or emails. The company was founded in 2014 and is based in San Francisco, California, United States.

THE WELL

Series A in 2019
THE WELL is a modern membership-based wellness club designed for busy urban professionals. They bring together Western doctors and Eastern healers to collaborate, developing online content and personalized products and experiences that empower their community to take greater agency for their health. The company recognizes both the benefits of Western medicine and the wisdom of Eastern healing and have built a science-backed ecosystem for wellness. The Well's integrative medicine doctors, health coaches, and skilled practitioners work together under one roof to build customized plans uniquely suited to each member and their goals.

Inozyme

Series A in 2019
Inozyme is a provider of therapies for rare diseases of calcification affecting soft tissues and bone created to offer potentially disease-modifying therapies to help children who are affected with rare, but severe and debilitating disorders of metabolism. The company's enzyme replacement therapy provides the treatment of Generalized Arterial Calcification of Infancy (GACI) and Autosomal Recessive Hypophosphatemic Rickets Type 2 (ARHR2), enabling patients to treat diseases characterized by mineral imbalances in the body.

Attest

Series A in 2019
Attest is a fast-scaling, SaaS business based in London and New York, and backed by investors including NEA, one of Silicon Valley's most prolific venture capital firms with over 225 portfolio company IPOs since 1977. Attest is a consumer research platform that delivers consumer data that drive predictable and repeatable growth to businesses. The Attest platform enables businesses to engage directly with >110 million consumers across >45 countries, starting in 90 seconds. Attest enables businesses to learn, measure, and grow ever-faster, across marketing, product, brand, innovation, competition, pricing, and beyond. Great companies put consumers and data at the heart of every decision. Attest makes this possible for anyone in any business, continuously, on a global scale. Clients use Attest to crack their greatest growth problems and fill the most valuable gaps in their knowledge, informing real decisions with fresh new inputs every day.

POLYNEURON

Series A in 2019
Polyneuron is a developer of novel therapeutics intended to facilitate the treatment of antibody-mediated autoimmune diseases. The company's biodegradable glycopolymers-based therapeutics selectively eliminate the pathological autoantibodies, while leaving the rest of the immune system intact, enabling medical practitioners to treat patients with immune disorders in a safe and effective manner.

Landit

Series A in 2019
Landit, Inc. operates a talent management platform focused on supporting women and diverse groups in the workplace. Founded in 2014 and based in New York, the company offers a personalized career development solution that helps organizations attract, develop, and retain high-potential talent. Landit's platform provides each member with a tailored playbook that includes tools, resources, executive coaching, and connections essential for professional growth. Key features of the platform encompass building personal brands, creating personal advisory boards, and facilitating curated skill development aligned with career opportunities. Through these offerings, Landit aims to enhance the success and engagement of women and diverse individuals in their careers.

Outrider

Series A in 2019
Outrider is a software company automating logistics hubs with electric, self-driving trucks. The company helps large enterprises improve safety and increase efficiency. Outrider works with logistics-dependent enterprises to eliminate manual tasks that are hazardous and repetitive.

Dandelion Energy

Series A in 2019
Dandelion Energy, Inc., founded in 2017 and headquartered in Palo Alto, California, specializes in affordable geothermal heating and cooling solutions for residential properties. The company's innovative home geothermal system replaces traditional air conditioning and heating equipment with a heat pump and underground pipes that efficiently transfer thermal energy between the earth and the home. This proprietary installation process allows homeowners to transition from conventional heating fuels to renewable geothermal energy, providing an environmentally friendly and cost-effective alternative for temperature regulation and hot water production.

Dandelion

Series A in 2019
Dandelion is a developer and provider of a marketing platform designed to facilitate the seamless discovery of content and commerce. The company enables sellers and service providers to utilize existing content, such as product catalogs and marketplace listings, to create effective advertisements. These ads can be deployed across social media channels, thereby enhancing marketing efforts. Dandelion's vision is to empower individuals and businesses to easily engage in marketing activities, fostering an environment where anyone can participate as a marketer in addition to being a seller.

FabFitFun

Series A in 2019
FabFitFun offers subscription services that allow its members to discover brands and products. FabFitFun is a team of self-starters, working together to achieve their mission. It’s a fast-paced environment, but they always take the time to celebrate birthdays, big wins, and cheer each other on. abFitFun was founded in 2010 and is backed by tier-one investors, including New Enterprise Associates, Upfront Ventures, and Simon Venture Group.

Timescale

Series A in 2019
Timescale is the modern cloud platform built on PostgreSQL for time-series, events and analytics. Timescale is dedicated to serving software developers and businesses worldwide, enabling them to build the next wave of computing. Timescale has a global workforce and is backed by Benchmark, New Enterprise Associates, Redpoint, Icon, Tiger Global, Two Sigma Ventures, and other leading investors. For more information, visit www.timescale.com or follow @TimescaleDB.

Jyve

Series A in 2019
Jyve is a tech platform that matches brands’ in-store execution needs with the right skilled labor, at the right time. Operational in most of America, Jyve offers brands access to certified skilled Jyvers who are complete asks to handle tasks including stocking, auditing, ordering and display building.

Tiburio Therapeutics

Series A in 2019
Tiburio Therapeutics, Inc. is a biotechnology company focused on developing and manufacturing medicines for diseases related to the endocrine system. Founded in 2018 and based in Cambridge, Massachusetts, the company is advancing clinical-stage compounds aimed at treating rare neuroendocrine tumors and endocrine diseases. Notably, Tiburio is developing TBR-760, which targets non-functioning pituitary adenoma using a dopamine-somatostatin chimeric molecule designed to shrink or halt tumor growth. Additionally, Tiburio is working on TBR-065 for other rare endocrine diseases, addressing significant patient needs in these underserved areas.

Big Data Federation

Venture Round in 2019
Big Data Federation is an AI-driven financial technology company that applies innovative machine-learning technologies to big data to predict financial and economic fundamentals metrics. Big Data Federation's home-grown scalable platform processes billions of data points from their growing library of data sources. Continuously-learning proprietary algorithms select and interconnect ecosystem data to generate highly accurate real-time predictions across companies, industries, economies, currencies, and commodities. These insights provide the foundations for short- and long-term investment decisions, business strategic planning, and fiscal and monetary economic policies. By leveraging advanced technologies to compute how connected global trends inform the future, Big Data Federation is paving the way to a more stable and prosperous modern economy.

BlackBird

Series A in 2019
BlackBird Air Inc. is a technology-driven company based in San Francisco that provides online travel services through its website and mobile application. Founded in 2016, the company connects travelers with private plane owners and commercial pilots, allowing passengers to easily rent aircraft while setting their own pickup and drop-off times. By offering a platform that facilitates this connection, BlackBird aims to enhance personal transportation options beyond traditional driving, addressing the limitations and frustrations associated with conventional travel methods. As of February 2020, BlackBird operates as a subsidiary of Surf Air Inc.

Forethought

Series A in 2018
Launched in 2018, Forethought is a generative AI for customer service automation to maximize efficiency and productivity. Forethought’s products enable seamless customer experiences by infusing generative AI, powered by Large Language Models (LLMs), at each stage of the customer support journey: resolving common cases instantly, predicting and prioritizing cases, and assisting agents with relevant knowledge—all from one platform.

Mojo Vision

Series A in 2018
Mojo Vision is focused on developing and commercializing high-performance micro-LED display technology for consumer, enterprise, and government applications. The company combines breakthrough technology, leading display and semiconductor expertise, and an advanced 300mm manufacturing process to deliver on the promise of micro-LED displays. Mojo’s proprietary quantum-dot technology brings full-color capability to its display platform and meets the superior performance demands for all form factors. Mojo Vision developed the world’s smallest, densest dynamic display for the first AR smart contact lens and is now applying this innovation and expertise to lead the disruption of the $160 billion display industry. Mojo Vision was founded in 2015 and headquartered in Saratoga, California.

Sleep Reset

Series A in 2018
Sleep Reset is a personalized, science-backed sleep program that offers a comprehensive solution for better sleep. Clinically proven to reduce insomnia symptoms, Sleep Reset has shown remarkable results, increasing total sleep time by an average of 85 minutes for individuals with short sleep durations. It also significantly reduces the time it takes to fall asleep and the frequency of nightly awakenings by approximately half. With Sleep Reset, you'll receive a dedicated sleep coach who tailors the program to your specific needs, addressing the root causes of your sleep issues. This personalized approach ensures long-term effectiveness, providing you with a sustainable solution to improve your sleep within just a few weeks, all without the need for pills or melatonin. Sleep Reset was developed in collaboration with renowned sleep experts from leading sleep clinics and universities, such as Stanford and Yale. Its credibility is further supported by its recognition in notable publications like Forbes, TechCrunch, and INSIDER. Additionally, Sleep Reset has received backing from prestigious Silicon Valley investors, including YCombinator, Foundation Capital, New Enterprise Associates, Stanford University, and numerous founders and executives from prominent companies.

Mirum Pharmaceuticals

Series A in 2018
Mirum Pharmaceuticals is a biopharmaceutical company dedicated to developing and commercializing therapies for serious liver diseases. Founded in 2018 and based in Foster City, California, the company focuses on addressing rare and orphan diseases. Its lead product candidate, maralixibat, is an investigational oral drug currently in Phase 3 clinical trials for treating progressive familial intrahepatic cholestasis (PFIC), Alagille syndrome (ALGS), and biliary atresia. Additionally, Mirum is developing volixibat, aimed at treating intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. The company’s commitment to innovative therapies positions it as a key player in the biopharmaceutical landscape dedicated to improving the lives of patients with debilitating liver conditions.

WireWheel

Series A in 2018
WireWheel.io is a software company that revolutionizes data privacy and protection as-a-service for companies. WireWheel delivers a cloud-based solution to to help global organizations become GDPR-ready and operationalize privacy in the enterprise.

Qpex Biopharma

Series A in 2018
Qpex Biopharma develops a pipeline of agents addressing critical needs for the treatment of infectious diseases. It develops multiple antibiotic drugs intended to combat antimicrobial resistance. The company's technology is focused on targeting the treatment of infectious diseases for both inpatient and outpatient cases, deep expertise in the discovery, development and regulatory approval of anti-infective medicines, including an extensive record of working with public/private partnerships focused on new antibiotics to combat antimicrobial resistance, enabling medical businesses optimal use of products and critical needs for the treatment of infectious diseases in the inpatient and outpatient settings. It was founded in 2018 and is headquartered in San Diego, California.

Naaptol

Venture Round in 2018
Koku Gamer is an online platform that offers gaming related news, editorials, reviews, previews, and other content. It was launched in March 2009.

Naked Labs

Series A in 2018
Naked Labs is a Silicon Valley-based startup focused on3D scanning, computer vision, and human-centered design. It uses infrared light to capture a 3D body model, which is visualized on the Naked app. The company was founded in 2015 and is headquartered in Redwood City, California.

Akouos

Series A in 2018
Akouos is a biotechnology company focusing on restoring and preserving hearing. The company leverages adeno-associated viral (AAV) vector-based gene therapy in order to restore and preserve hearing in genetically-defined patient populations in a range of forms, from a single genetic mutation to ototoxic drug exposure and to the aging process, enabling the healthcare industry to treat sensorineural hearing loss in an efficient manner.

Automation Anywhere

Series A in 2018
Automation Anywhere is a global company that specialises in Robotic Process Automation, offering AI-powered software bots that automate repetitive tasks. The company's cloud-native platform integrates RPA, artificial intelligence, machine learning, and analytics to enhance productivity, customer experience, and employee engagement.

Waterbit

Series A in 2018
WaterBit’s automated irrigation solution enables control of local irrigation taking into account growth stage and soil conditions at a level of granularity and accuracy that is not possible with other current methods. WaterBit translates technology into tangible value for growers to improve yields, ensure crop quality, optimize water usage and implement labor saving strategies.

PlayVS

Series A in 2018
PlayVS operates an esports platform designed to facilitate competitive gaming for high school students. The platform enables the organization of online tournaments where teens can form teams at their schools and compete against teams from other schools for cash prizes and titles at state championships. It serves as a comprehensive resource for high school esports programs, keeping participants informed and engaged in the competitive gaming landscape.

Bestow

Series A in 2018
Bestow Inc. is a digital insurance company based in Dallas, Texas, that specializes in providing accessible life insurance services. Founded in 2016, Bestow utilizes data-driven technology and algorithmic underwriting to evaluate risks and streamline the insurance process. The company caters primarily to individuals and busy families, allowing them to obtain affordable life insurance policies quickly and conveniently through a fully digital platform. Customers can complete their applications in minutes without the need for agents, lengthy forms, or medical exams. Additionally, Bestow offers APIs that enable partners to integrate life insurance coverage into their own services, broadening the market reach of their products.

Maisonette

Series A in 2018
Maisonette provides an online shopping platform that offers baby and children's fashion and lifestyle products. The platform curates and aggregates a diverse and differentiated assortment of quality apparel, accessories, toys, furniture, and home decor for children ages 0-12 via a global network of brands and boutiques, enabling parents with a one-stop shopping destination for style-driven, quality products at every price point.

Dreams

Series A in 2018
Dreams is a mobile-only TV platform that redesigns TV for the most important device. Dreams developed patent-pending computer vision technology to create a modern, mobile-first TV news experience. The company’s software converts live TV news into a vertical video format in real-time, enabling the first-ever live, 24/7 vertical video news channels. Dreams is available for free in the U.S. on the App Store and Google Play. The app requires no login or registration. It was founded in New York City in 2016 by Tom Bender and Greg Hochmuth.

Vesper Medical

Series A in 2018
Vesper Medical is committed to developing safe, efficacious and easy-to-use products for patients with deep venous disease and the physicians who treat them. The company's core technology, the Vesper DUO Venous Stent System, is purpose-built for venous stenting, with an unmatched combination of strength and flexibility designed to meet the multiple anatomical challenges presented by vein mechanics. Vesper Medical is advancing the treatment of deep venous disease by creating a highly differentiated, purpose-built venous stent portfolio that addresses the multiple anatomical challenges presented by the iliac and femoral veins. It also develops minimally- invasive peripheral vascular products. Vesper Medical was founded in 2016 and is headquartered in Wayne, PA, USA.

Canopy

Venture Round in 2018
Canopy offers a cloud-based Practice Management solution for Accounting firms. This includes CRM, Client Portal, Document Management, eSignatures, Workflow, Time & Billing, Payments, Tax Resolution, and Transcripts and Notices.

Burrow

Series A in 2018
Burrow, Inc. is a New York-based furniture company that designs, manufactures, and supplies a range of home furnishings, including customizable sofas, sectionals, loveseats, armchairs, and ottomans, as well as tables, rugs, and various accessories. Founded in 2016, Burrow focuses on creating luxury furniture that is both easy to move and comfortable, utilizing sustainably-sourced hardwood and non-toxic, scratch- and stain-resistant fabrics. The company aims to reinvent the home furnishing experience by offering personalized and durable products that allow customers to avoid traditional retail markups. Burrow sells its items through physical showrooms in several states, including Washington, Massachusetts, Texas, and California, as well as through its online platform. The company's manufacturing facility is located in Mexico City, Mexico.

Radiology Partners

Venture Round in 2018
Radiology Partners Holdings, LLC, founded in 2012 and headquartered in Manhattan Beach, California, operates within the healthcare sector as a radiology practice center. The company is dedicated to transforming the way radiologists deliver services, catering to hospitals, referring physicians, and patients. By focusing on enhancing the efficiency and effectiveness of radiology services, Radiology Partners aims to improve patient care and support healthcare facilities in meeting their diagnostic needs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.